Heinz-Josef Klümpen

13PUBLICATIONS
99CO-AUTHORS
Haematological tumoursCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 27, 2026
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.

Stephen L Chan, Thomas Yau, Robin K Kelley

|Dec 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Feb 08, 2024
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial).

Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel

|Jul 19, 2022
Rare cancer and return to work: experiences and needs of patients and (health care) professionals.

Daphne L T Olischläger, Li Xiang Y den Boer, Eline de Heus

|Jun 23, 2022
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres.

Wouter T Zandee, Elettra Merola, Karolina Poczkaj

|May 28, 2022
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry.

Lynn E Nooijen, Jesus M Banales, Marieke T de Boer

Pageof 3

Frequent Collaborators

4 joint publications

Julien Edeline

3 joint publications

Tim A Labeur

3 joint publications

R Bart Takkenberg

3 joint publications

Otto M van Delden